menu
    • menu

    Company profile for Akari Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We develop life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Akari Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    75/76 Wimpole Street London W1G 9RT
    Telephone
    Telephone
    +44 (0)20.8004.0261
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.akaritx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Akari Highlights AKTX-101's Promise in K-Ras Pancreatic Cancer
    Akari Highlights AKTX-101's Promise in K-Ras Pancreatic Cancer

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202382/0/en/Akari-Therapeutics-Highlights-Preclinical-Data-Demonstrating-Therapeutic-Potential-of-Lead-Candidate-AKTX-101-for-Hard-to-Treat-K-Ras-Mutant-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Akari Pharma Updates On ADC Payload Innovation In New CEO Corner
    Akari Pharma Updates On ADC Payload Innovation In New CEO Corner

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199869/0/en/Akari-Therapeutics-Provides-Corporate-Update-and-Highlights-its-ADC-Payload-Innovation-Expected-to-Drive-Value-in-New-CEO-Corner-Segment.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Akari Pharma Unveils New CEO Corner Segment
    Akari Pharma Unveils New CEO Corner Segment

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194384/0/en/Akari-Therapeutics-Announces-Release-of-the-Next-CEO-Corner-Segment.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Akari Therapeutics Names Farag as Interim CFO
    Akari Therapeutics Names Farag as Interim CFO

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3190042/0/en/Akari-Therapeutics-Appoints-Biotech-Finance-Leader-Kameel-D-Farag-as-Interim-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Akari Therapeutics Presents Splicing-Targeted ADC Payload Data
    Akari Therapeutics Presents Splicing-Targeted ADC Payload Data

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184579/0/en/Akari-Therapeutics-Presents-Promising-Immuno-Oncology-Data-for-its-Novel-Splicing-Targeted-ADC-Payload-Driving-Immune-Activation-Both-as-Single-Agent-and-in-Combination-with-Anti-P.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Akari Releases Abstract on Splicing-Targeted ADC Payload
    Akari Releases Abstract on Splicing-Targeted ADC Payload

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180483/0/en/Akari-Therapeutics-Accepted-Abstract-Showcasing-its-Novel-Splicing-Targeted-ADC-Payload-Driving-Immune-Activation-Now-Available.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search